Millennium Management’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSI
FLAM
AIC
NCM
WA
VCM
GGHC
TSW
Millennium Management's TLSI Position: Q1 2026 in Review
Millennium Management sold out of TriSalus Life Sciences (TLSI) in Q1 2026, closing a stake of 35,679 shares — an estimated $249K sold.
Millennium Management first reported a position in TLSI in Q2 2021 and held it in 14 quarters. The position peaked at $6.52M in Q1 2022. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.
- Millennium Management reported no remaining TriSalus Life Sciences position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 35,679 TriSalus Life Sciences shares in Q1 2026, an estimated $249K.
- Millennium Management first reported a position in TriSalus Life Sciences in Q2 2021 and held it in 14 quarters.
- Millennium Management's TriSalus Life Sciences position peaked at $6.52M in Q1 2022.
- 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.